Frontlight ResearchEarly access
Trial site
Zala Megyei Szent Rafael Korhaz
- 4running trials
- 7closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes4 trials
- Coronary artery disease2 trials
- Lung cancer2 trials
- Obesity2 trials
- Asthma1 trial
- Chronic kidney disease1 trial
- COPD1 trial
- Diabetic eye disease1 trial
- Heart failure1 trial
- Kidney cancer1 trial
- Macular degeneration1 trial
- Ovarian cancer1 trial
- and 2 more
- Phase
- Phase 39 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Anji Pharma1 trial
- CanariaBio Inc.1 trial
- Chiesi Hungary Ltd.1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- and 5 more
Running trials
Recruiting
Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026